Brief: Neurocrine Biosciences Appoints Samir Siddhanti Chief Business Officer
21/07/2026 23:31
BRIEF-Neurocrine Biosciences Appoints Samir Siddhanti Chief Business Officer July 21 (Reuters) - Neurocrine Biosciences, Inc NBIX.O:
NEUROCRINE BIOSCIENCES APPOINTS SAMIR SIDDHANTI CHIEF BUSINESS OFFICER
Source text: ID:nPn5kpmxRa
Further company coverage: NBIX.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Neurocrine Biosciences
See all newsBrief: Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating Nbi-'567 In Adults With Alzheimer's Disease
Nxera Pharma's Partner Neurocrine Biosciences Receives Ind Acceptance From FDA For Phase 2 Study Of Nbi-1117567 For Alzheimer's Cognition
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Prader-Willi groups cite deaths tied to Neurocrine's genetic disorder drug, shares fall